🇺🇸 FDA
Patent

US 12318427

Methods and compositions for modulation of tau proteins

granted A61KA61K38/1709A61K48/0075

Quick answer

US patent 12318427 (Methods and compositions for modulation of tau proteins) held by Sangamo Therapeutics, Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/1709, A61K48/0075, A61K9/0019, A61P